* Treatment with anakinra, an interleukin 1 receptor antagonist, can lead to an improvement in the hearing loss. * Rilonacept (Arcalyst) a dimeric fusion protein for the treatment of CAPS. * Canakinumab, a monoclonal antibody against interleukin-1β
Muckle–Wells syndrome
GRACILE syndrome
Kindler syndrome
Hurler syndrome
Hay–Wells syndrome
Hajdu–Cheney syndrome
Alagille syndrome
Hecht Scott syndrome